Epilepsy is a neurological condition marked by recurrent seizures. It affects over 50 million people worldwide, making it one of the most common neurological disorders. The exact cause of epilepsy is unknown, but it is believed to result from abnormal electrical activity in the brain.
Epilepsy can manifest in various forms, with different types of seizures. Common types include generalized tonic-clonic seizures (grand mal seizures), characterized by convulsions and loss of consciousness; absence seizures (petit mal seizures), characterized by brief lapses in attention; and focal seizures, which affect only a specific part of the brain. The severity and frequency of seizures can vary widely from person to person.
Despite the challenges, significant progress is being made in developing new treatment options for epilepsy. Advancements in medical research have led to the development of new medications, surgical techniques, and devices that have improved the management and control of seizures. Additionally, there is ongoing research into potential gene therapies and neuromodulation techniques that could revolutionize the treatment landscape. With dedicated efforts and continued research, the future for people living with epilepsy holds promise for improved seizure control, reduced medication side effects, and potentially even the possibility of a cure.
Few of the trials for this disease are listed below.

© 2023-24 DxMultiomics. All rights reserved.